Н. Л. Пульнова

Н. Л. Пульнова

Auto-generated profile, based on publicly available information

Н. Л. Пульнова

The Gamaleya National Center of Epidemiology and Microbiology of the Ministry of Health of Russian Federation

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2022 in CHILDREN INFECTIONS
Verified
Journal Article
Open access
PDF file
НПН. Л. Пульнова
Н. Л. Пульнова
TRT. N. Rybalkina
T. N. Rybalkina
NKN. V. Karazhas
N. V. Karazhas
RBR. E. Bosh’iAn
R. E. Bosh’iAn
MKM. N. Kornienko
M. N. Kornienko
OSO. V. Silina
O. V. Silina
Infections occupy one of the central places among the complications of transplants. The frequency of fatal infectious complications during the first twelve months after transplantation ranges from 2.6 to 51.7%. Identifying markers of opportunistic infections before transplantation will help reduce the likelihood of developing these infections after induced immunosuppression. The aim of the study was to study the role of herpesviruses and pneumocysts in the occurrence of infectious complications in children before and after liver transplantation based on the detection of markers of a number of herpesvirus infections and pneumocystosis. The article presents the results of a comprehensive examination for markers of herpesvirus infections and pneumocystosis of 70 children who were treated at the Shumakov Transplantation Research Center. It should be noted that 55 patients (78.6%) were diagnosed with infectious complications, of which 46 people (65.7%) had pneumonia. To detect IgM and IgG antibodies to herpesviruses and pneumocysts, peripheral blood serum samples were examined by enzyme immunoassay (ELISA). Detection of common HBV antigens was carried out by indirect immunofluorescence reaction (NRIF). Early antigens and reproduction of herpesviruses were detected by rapid culture method (BCM) on Vero and M-19 cell cultures for CMVI. In the event of infectious complications (pneumonia) in children who underwent related liver transplantation, the number of patients with active EBI markers increased almost 7 times and active HCV-6 markers increased 3.5 times. The paper shows the need for a broader laboratory screening of opportunistic infections, which will serve to achieve better clinical results, contribute to the formation of more advanced diagnostic algorithms, as well as improve epidemiological surveillance of these infections.

20 April 2026 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Closed access
PDF file
ESE. R. Samitova
E. R. Samitova
IOI. M. Osmanov
I. M. Osmanov
NKN. V. Karazhas
N. V. Karazhas
EME. I. Makarova
E. I. Makarova
LTL. O. Tarantov
L. O. Tarantov
НЛН. В. Лобань
Н. В. Лобань
Pneumocystis is a well-studied disease that usually develops in immunocompromised patients, especially in patients with HIV infection, and also in patients with systemic rheumatic diseases, organ transplant patients, including glucocorticosteroids and biological drugs, leading to an increased incidence of opportunistic infections, including Pneumocystis pneumonia. This is a serious complication with high mortality. In recent years, there has been an increase in the number of cases of pneumocystis in immunocompetent children without concomitant diseases. Timely diagnosis and treatment of Pneumocystis pneumonia in children depend on the vigilance of general practitioners, pediatricians and infectious disease specialists, as well as their knowledge of the clinical picture of the disease. The article describes a rare clinical case of generalized pneumocystosis with lung and intestinal damage in a 5-year-old child.

8 June 2024 in Surgery and Oncology
Verified
Journal Article
Open access
PDF file
VAV. V. Aginova
V. V. Aginova
ZGZ. V. Grigoryevskaya
Z. V. Grigoryevskaya
NKN. V. Karazhas
N. V. Karazhas
IPI. N. Petukhova
I. N. Petukhova
NPN. L. Pul’NOva
N. L. Pul’NOva
KLK. K. Laktionov
K. K. Laktionov
Aim. To investigate the species composition and frequency of opportunistic pathogens in cancer patients diagnosed with non-small cell lung cancer (NSCLC) receiving chemotherapeutic treatment at the Federal State Budgetary Institution National Medical Research Center of Oncology named after N. N. Blokhin of the Russian Ministry of Health.Materials and methods. A prospective open single-center study included a cohort of patients with locally advanced or metastatic NSCLC receiving drug antitumor therapy, aged 18 years and older. The study was observational in nature. The endpoint of this phase of the study was to determine the relative number of NSCLC patients with chronic infection (pneumocystis, herpes simplex virus (HSV) 1, HSV-2, cytomegalovirus (CMV), Epstein–Barr virus (EBV), human herpes virus type 6 (HHV-6) and their combinations).Results. Antibodies to herpes viruses and/or pneumocystis were detected in patients (n = 18) diagnosed with NSCLC in 100 % of cases. Antibody titers corresponding to active infection were more characteristic for EBV and CMV, with CMV infection markers more often registered in titers corresponding to the acute stage of the disease, and EBV – in the reactivation stage without obvious clinical manifestations. In most cases, mixed infection with different pathogens was determined: combination of HSV-1 + EBV + CMV was found in 55.5 % (n = 10) of NSCLC patients; HSV-1 + EBV + CMV + HHV-6 – in 33.3 % (n = 6) of cases, HSV-1 + HSV-2 + EBV + CMV – in 5.5 % (n = 1), HSV-1 + HSV-2 + EBV + CMV + HHV-6 also in 5.5 % (n = 1) of patients. During bronchoalveolar lavage examination, pneumocystis were detected in 3 (42.8 %) out of 7 examined patients.Conclusion. Based on the results of studies of a relatively small cohort of patients in the absence of clinical symptoms of infection in NSCLC patients, a high percentage of IgM and IgG antibodies, which are markers of opportunistic infections and their combinations, were detected. Pneumocystis was isolated from bronchoalveolar lavage in 42.8 % of cases. It is necessary to evaluate the results obtained in a larger number of patients to determine approaches to the prevention and treatment of opportunistic infections.